NCT01409408 Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan Status WITHDRAWN Phase PHASE4
NCT01406977 Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP) Status COMPLETED Phase PHASE2
NCT01406548 Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density Status COMPLETED Phase PHASE2
NCT01404676 The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01404650 Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor Status COMPLETED Phase PHASE2
NCT01400074 Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib Status UNKNOWN Phase PHASE3
NCT01396499 Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias Status COMPLETED Phase PHASE1
NCT01392183 Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2
NCT01386723 End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia Status TERMINATED Phase N/A
NCT01379469 Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency Status TERMINATED Phase PHASE2
NCT01361334 Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible Status COMPLETED Phase PHASE2
NCT01360385 Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab Status COMPLETED Phase N/A
NCT01352312 Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma Status TERMINATED Phase PHASE1
NCT01349660 Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT01349114 Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects Status TERMINATED Phase PHASE4
NCT01343498 Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01341834 Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors Status UNKNOWN Phase PHASE1
NCT01336959 Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery Status TERMINATED Phase PHASE2